@prefix geo: <http://www.w3.org/2003/01/geo/wgs84_pos#> .
  @prefix eprel: <http://eprints.org/relation/> .
  @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
  @prefix dc: <http://purl.org/dc/elements/1.1/> .
  @prefix epid: <https://arxiv.universalpublishings.com/id/> .
  @prefix doi: <https://doi.org/> .
  @prefix event: <http://purl.org/NET/c4dm/event.owl#> .
  @prefix owl: <http://www.w3.org/2002/07/owl#> .
  @prefix bibo: <http://purl.org/ontology/bibo/> .
  @prefix cc: <http://creativecommons.org/ns#> .
  @prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
  @prefix dct: <http://purl.org/dc/terms/> .
  @prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
  @prefix ep: <http://eprints.org/ontology/> .
  @prefix void: <http://rdfs.org/ns/void#> .
  @prefix foaf: <http://xmlns.com/foaf/0.1/> .
  @prefix skos: <http://www.w3.org/2004/02/skos/core#> .

<>
	foaf:primaryTopic <https://arxiv.universalpublishings.com/id/eprint/61043>;
	rdfs:comment "The repository administrator has not yet configured an RDF license."^^xsd:string .

<https://arxiv.universalpublishings.com/id/eprint/61043#authors>
	rdf:_1 <https://arxiv.universalpublishings.com/id/person/ext-8be8660e3009da9619fcd7002c98af13>;
	rdf:_2 <https://arxiv.universalpublishings.com/id/person/ext-d666ac9fa3464add4700e3cc926fa6f0> .

<https://arxiv.universalpublishings.com/id/eprint/61043/>
	dc:format "text/html";
	dc:title "HTML Summary of #61043 \n\nNOVEL TREATMENT APPROACHES IN REACTIVE ARTHRITIS: CLINICAL AND CYTOKINE RESPONSES TO IGURATIMOD 25 MG COMPARED WITH BIOLOGIC AND CONVENTIONAL THERAPIES\n\n";
	foaf:primaryTopic <https://arxiv.universalpublishings.com/id/eprint/61043> .

<https://arxiv.universalpublishings.com/id/eprint/61043>
	bibo:abstract "Reactive Arthritis (ReA) is an immune-mediated form of spondyloarthritis, often triggered by genitourinary or gastrointestinal infections. Current therapeutic strategies rely mainly on NSAIDs and cs-DMARDs, with biologics reserved for refractory disease. However, limited progress has been made in exploring novel targeted agents. Iguratimod 25 mg, an oral immunomodulatory drug approved for rheumatoid arthritis in Asia, has demonstrated anti-inflammatory and cytokine-suppressive properties, but evidence in ReA is scarce"^^xsd:string;
	bibo:authorList <https://arxiv.universalpublishings.com/id/eprint/61043#authors>;
	bibo:status <http://purl.org/ontology/bibo/status/published>;
	dct:creator <https://arxiv.universalpublishings.com/id/person/ext-8be8660e3009da9619fcd7002c98af13>,
		<https://arxiv.universalpublishings.com/id/person/ext-d666ac9fa3464add4700e3cc926fa6f0>;
	dct:date "2025-12-08";
	dct:isPartOf <https://arxiv.universalpublishings.com/id/repository>,
		<https://arxiv.universalpublishings.com/id/publication/ext-b6530cc07ed9d05480e619db77ea5cb1>;
	dct:publisher <https://arxiv.universalpublishings.com/id/org/ext-dce91bc34ec9a52b0fb2d7899759e2d8>;
	dct:title "NOVEL TREATMENT APPROACHES IN REACTIVE ARTHRITIS: CLINICAL AND CYTOKINE RESPONSES TO IGURATIMOD 25 MG COMPARED WITH BIOLOGIC AND CONVENTIONAL THERAPIES"^^xsd:string;
	rdf:type bibo:AcademicArticle,
		bibo:Article,
		ep:ArticleEPrint,
		ep:EPrint;
	rdfs:seeAlso <https://arxiv.universalpublishings.com/id/eprint/61043/> .

<https://arxiv.universalpublishings.com/id/org/ext-dce91bc34ec9a52b0fb2d7899759e2d8>
	foaf:name "\"Research Science and Innovation house\" LLC"^^xsd:string;
	rdf:type foaf:Organization .

<https://arxiv.universalpublishings.com/id/person/ext-8be8660e3009da9619fcd7002c98af13>
	foaf:familyName "Mullokulov"^^xsd:string;
	foaf:givenName "Javohir"^^xsd:string;
	foaf:name "Javohir Mullokulov"^^xsd:string;
	rdf:type foaf:Person .

<https://arxiv.universalpublishings.com/id/person/ext-d666ac9fa3464add4700e3cc926fa6f0>
	foaf:familyName "Akhmedov"^^xsd:string;
	foaf:givenName "Khalmurad"^^xsd:string;
	foaf:name "Khalmurad Akhmedov"^^xsd:string;
	rdf:type foaf:Person .

<https://arxiv.universalpublishings.com/id/publication/ext-b6530cc07ed9d05480e619db77ea5cb1>
	foaf:name "Journal of Universal Science Research"^^xsd:string;
	rdf:type bibo:Collection .